Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases

Annals of Hematology

Volumn 94, Issue 1, 2015, Pages 89-95

  Leclerc, Mathieu ^a   Suarez, Felipe ^b   Noël, Marie Pierre ^c   Vekhoff, Anne ^d   Troussard, Xavier ^e   Claisse, Jean François ^f   Thieblemont, Catherine ^g   Maloisel, Frédéric ^h   Beguin, Yves ⁱ   Tamburini, Jérôme ^j   Barbe, Coralie ^a   Delmer, Alain ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

^f AMIENS UNIVERSITY HOSPITAL   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h Centre du sommeil de la clinique Sainte Barbe   (France)

ⁱ UNIVERSITY OF LIÈGE   (Belgium)

^j Institut Cochin   (France)

more..

Author keywords

Chronic leukemias; Hairy cell leukemia; Immunotherapy; Rituximab

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; AGED; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84920075979     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2175-0     Document Type: Article

References (23)

1. Foucar K, Falini B, Catovsky D, Stein H (2008) Hairy cell leukaemia, vol 1. WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon
2. Bouroncle BA (1979) Leukemic reticuloendotheliosis (hairy cell leukemia). Blood 53(3):412–436
3. Spiers AS, Moore D, Cassileth PA, Harrington DP, Cummings FJ, Neiman RS, Bennett JM, O’Connell MJ (1987) Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin). N Engl J Med 316(14):825–830
4. Piro LD, Carrera CJ, Carson DA, Beutler E (1990) Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322(16):1117–1121
5. Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O’Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D (2009) Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 145(6):733–740
6. Jones G, Parry-Jones N, Wilkins B, Else M, Catovsky D (2012) Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*. Br J Haematol 156(2):186–195
7. Flinn IW, Kopecky KJ, Foucar MK, Head D, Bennett JM, Hutchison R, Corbett W, Cassileth P, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson B, Grever MR (2000) Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 96(9):2981–2986
8. Hagberg H (1999) Chimeric monoclonal anti-CD20 antibody (rituximab)—an effective treatment for a patient with relapsing hairy cell leukaemia. Med Oncol 16(3):221–222
9. Lauria F, Lenoci M, Annino L, Raspadori D, Marotta G, Bocchia M, Forconi F, Gentili S, La Manda M, Marconcini S, Tozzi M, Baldini L, Zinzani PL, Foa R (2001) Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia. Haematologica 86(10):1046–1050
10. Hagberg H, Lundholm L (2001) Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia. Br J Haematol 115(3):609–611
11. Nieva J, Bethel K, Saven A (2003) Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood 102(3):810–813
12. Thomas DA, O’Brien S, Bueso-Ramos C, Faderl S, Keating MJ, Giles FJ, Cortes J, Kantarjian HM (2003) Rituximab in relapsed or refractory hairy cell leukemia. Blood 102(12):3906–3911
13. Zenhausern R, Simcock M, Gratwohl A, Hess U, Bargetzi M, Tobler A (2008) Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98). Haematologica 93(9):1426–1428
14. Cervetti G, Galimberti S, Andreazzoli F, Fazzi R, Cecconi N, Caracciolo F, Petrini M (2008) Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up. Br J Haematol 143(2):296–298
15. Ravandi F, O’Brien S, Jorgensen J, Pierce S, Faderl S, Ferrajoli A, Koller C, Challagundla P, York S, Brandt M, Luthra R, Burger J, Thomas D, Keating M, Kantarjian H (2011) Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia. Blood 118(14):3818–3823
16. Else M, Dearden CE, Matutes E, Forconi F, Lauria F, Ahmad H, Kelly S, Liyanage A, Ratnayake V, Shankari J, Whalley I, Catovsky D (2011) Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence. Leuk Lymphoma 52(Suppl 2):75–78
17. Gerrie AS, Zypchen LN, Connors JM (2012) Fludarabine and rituximab for relapsed or refractory hairy cell leukemia. Blood 119(9):1988–1991
18. Matutes E, Morilla R, Owusu-Ankomah K, Houliham A, Meeus P, Catovsky D (1994) The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma 14(Suppl 1):57–61
19. Cervetti G, Galimberti S, Andreazzoli F, Fazzi R, Cecconi N, Caracciolo F, Petrini M (2004) Rituximab as treatment for minimal residual disease in hairy cell leukaemia. Eur J Haematol 73(6):412–417
20. Matutes E, Meeus P, McLennan K, Catovsky D (1997) The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up study. Br J Haematol 98(2):375–383
21. Malfuson JV, Doghmi K, Fagot T, Souleau B, De Revel T, Nedellec G (2006) Efficacy of rituximab in hairy cell leukemia. Presse Med 35(5 Pt 1):801–802
22. Buckstein R, Patel H, Chesney A, Reis M, Imrie K (2006) Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report. Hematology 11(4):267–270
23. Cornet E, Delmer A, Feugier P, Garnache-Ottou F, Ghez D, Leblond V, Levy V, Maloisel F, Re D, Zini J, Troussard X (2014) Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukemia. Ann Hematol In press